Clinical Trial

Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the efficacy of Eravacycline in the treatment of patients with bacterial infection and to assess the pharmacokinetics of Eravacycline and to establish a population pharmacokinetic model of Eravacycline.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-30.
Trial Details
NCT Number NCT06666998
Lead Sponsor Sichuan Provincial People's Hospital
Conditions Eravacycline, Pharmacokinetics, Bacteria Infection, Bacterial Resistance to Antimicrobial, Empirical Antimicrobial Therapy
Enrollment 100 participants
Start Date 2024-11-01
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-04